Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects (Q82732869)
Jump to navigation
Jump to search
scientific article published on 03 March 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects |
scientific article published on 03 March 2006 |
Statements
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects (English)
Wendy G Halpern
Patrick Lappin
Thomas Zanardi
Wendy Cai
Marta Corcoran
John Zhong
Kevin P Baker